Warning letter
Anatox Inc.: warning letter of Apr 26, 2017
FDA warning letter 508278 · Center for Food Safety and Applied Nutrition
Key facts
| Reference number | 508278 |
|---|---|
| Company | Anatox Inc. |
| Subject | CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated |
| Issue date | Apr 26, 2017 |
| Posted date | Dec 10, 2018 |
| Issuing office | Center for Food Safety and Applied Nutrition |
| Product type | Food/Cosmetics |
| CFR sections cited | 111, 111.70(b), 111.70(b)(1), 111.70(e), 111.75(h)(1), 111.95(b)(1), 111.75(a)(1)(i), 111.75(a)(1)(ii), 111.75(a)(2), 111.75(c) |
| Inspection city | Richland |
| Inspection ZIP | 65556 |
| Inspection start date | Aug 31, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: